Research
Energy balance
GLP-1 receptor agonists (like semaglutide) and hFGF21 analogs produce similar weight loss efficacy in mice regardless of whether they are housed at standard room temperature (22°C) or thermoneutrality (30°C).
For GLP-1 and hFGF21 drugs, the mouse model's housing temperature is less critical for predicting efficacy magnitude than for other drug classes. These drugs work robustly in both cold-stressed and thermoneutral environments.
GoodSupportsHIGH confidence
GLP-1, human fibroblast growth factor 21 (hFGF21), and melanocortin-4 receptor (MC4R) agonist induced similar weight losses.
Why this rating
Consistent results across multiple experiments for these specific drugs.
Source
Housing mice near vs. below thermoneutrality affects drug-induced weight loss but does not improve prediction of efficacy in humans
Julie Jacobsen et al. · Cell Reports · 2024
DOI 10.1016/j.celrep.2024.114501
mechanism_only · n=160Cited 19×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Housing mice at thermoneutrality (30°C) rather than standard room temperature (22°C) does not improve the prediction of human drug efficacy for weight loss, as the direction and magnitude of drug effects vary by mechanism regardless of temperature.Good
- GDF15 analogs are significantly more effective at inducing weight loss in mice housed at standard room temperature (22°C) compared to thermoneutrality (30°C), with efficacy dropping by half at higher temperatures.Good
- Peptide YY (PYY) analogs show greater weight loss efficacy in mice housed at thermoneutrality (30°C) compared to standard room temperature (22°C), contrary to the trend seen with GDF15.Good
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →